ATLANTA – (COMMERCIAL THREAD) –Genexa, the world’s first clean, over-the-counter pharmaceutical company, just completed its unprecedented $ 60 million Series A funding to advance its market leadership in this emerging space. Marking a landmark development in the consumer health industry, Genexa’s oversubscribed campaign was the largest Series A ever raised for an over-the-counter drug company, confirming the dramatic shift in consumers seeking cleaner options . Initially seeking $ 25 million in capital, Genexa stepped up the round due to the caliber of investors and celebrities who wanted to be involved in creating a cleaner and more transparent drug aisle.
“Genexa is pioneering a powerful movement that will revolutionize the over-the-counter drug industry in the years to come,” notes Brian perkins, president of Genexa and former global president of Consumer Pharmaceuticals & Nutritionals at Johnson & Johnson. “In an industry ripe for disruption, Genexa is making long-awaited formulation improvements with high-quality ingredients and setting a whole new standard and a whole new level of transparency in over-the-counter drugs. ”
Jared stein, co-founder and managing partner of Monogram capital led the round and was joined by some of the world’s most reputable investors including Unilever Ventures, Verlinvest, Northcastle Partners, and Capital of Pointe King. By joining this group of top investors, an equally powerful roster of famous wellness advocates, including Gwyneth Paltrow, Chris Pratt, Katherine schwarzenegger, Donald glover, Lily aldridge, Jennifer meyer, Regina Room, Sanaa Lathan, Don cheadle, Bridgid coulter, Lana parrilla, Patrick schwarzenegger, Tony Kanal, Zoey German, Brandon shainfeld and Angela Fletcher.
“Genexa heralds a radical change in medicine, giving consumers access to the first clean, better health and efficient option ever offered on the OTC market. Consumers have demanded better in every other facet of their lives, and with Genexa, they can finally do the same in their medicine cabinets, ”said the co-founder and managing partner of Monogram Capital. Jared stein. “We couldn’t be more proud to support David and Max’s mission to lead this generational category change. ”
Founded by David johnson and Max Spielberg, two fathers with a personal mission to find better medicines for their families, Genexa offers cleaner and more effective over-the-counter medicines covering all traditional categories of over-the-counter medicines including pain and fever, colds and sores. flu, as well as digestion and allergies, with products for infants, children and adults alike.
Genexa’s innovative and patented preservation system has allowed the company to set a new global standard for the industry, becoming the brand of choice for consumers seeking a healthier lifestyle. Genexa products contain the same effective active ingredients as the category leaders, but for the first time ever, without the unnecessary and potentially harmful fillers found in most other traditional OTC offerings. Their “Ex List”, the list of unnecessary ingredients often found in other brands that will never appear in Genexa formulas, includes sorbitol, propylene glycol, artificial colors, synthetic binders, talc. and common allergens like gluten and lactose.
Genexa products are available at more than 45,000 retailers nationwide, including Walmart, Target, CVS, Kroger, Target, Walgreens, Whole Foods and Sprouts, as well as online at Genexa.com and Amazon.
With pharmaceutical industry veterans like Perkins, the company has assembled a respected medical advisory board of leading experts.
“We did not accept the feedback we received from countless manufacturers who told us that artificial binders and fillers are needed in over-the-counter drugs to keep them stable. a better solution, ”said the co-founders of Genexa Johnson and Spielberg. “Through the innovative products we create and the advancements we have made with over-the-counter medications, we hope to inspire others in the industry to continue our mission of cleaning the medication aisle and offering better solutions. cleaner and healthier for everyone. ”
All Genexa products are manufactured according to FDA guidelines and are Project Verified for Non-GMOs and Gluten Free. Many are also certified organic and vegan. As a certified B-Corporation, Genexa is committed to using business as a force for good, upholding rigorous standards of social and environmental performance, accountability and transparency.
For more information visit Genexa.com.
Founded by two fathers with the goal of revolutionizing the drug aisle, Genexa makes drugs with the same active ingredients people need, but without the artificial ingredients they don’t have. We believe people deserve better. That’s why our business is built on a commitment to put people first. All of our products are made to the highest medical standards with no artificial colors, common allergens or unnecessary inactive ingredients. It’s real medicine, made clean. Find out how we put people above everything, in everything we do, at Genexa.com.
ABOUT CAPITAL MONOGRAM:
Based in Los Angeles, California and founded in 2014, Monogram Capital Partners focuses exclusively on investing in high-growth consumer and omnichannel brands with more than $ 500 million in capital under management. The company seeks to partner with strong founders and management teams, supporting category-leading brands including Chewy.com, Oatly, Country Archer, Olipop, Vive Organic and Foxtrot. Genexa represents the twenty-eighth company in the firm’s portfolio. To learn more about Monogram, please visit: www.monogramcapital.com.